{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T01:12:47Z","timestamp":1792717967374,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,7,1]],"date-time":"2003-07-01T00:00:00Z","timestamp":1057017600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2003,7]]},"DOI":"10.1038\/sj.bjc.6601038","type":"journal-article","created":{"date-parts":[[2003,7,15]],"date-time":"2003-07-15T13:14:20Z","timestamp":1058274860000},"page":"284-290","source":"Crossref","is-referenced-by-count":164,"title":["Prognostic factors for patients with hepatic metastases from breast cancer"],"prefix":"10.1038","volume":"89","author":[{"given":"L","family":"Wyld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Gutteridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S E","family":"Pinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J J","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Y","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K L","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J F R","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A J","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,7,15]]},"reference":[{"key":"BF6601038_CR1","doi-asserted-by":"crossref","unstructured":"British Breast Group (1974) Assessment of response to treatment in advanced breast cancer. Lancet ii: 38\u201339","DOI":"10.1016\/S0140-6736(74)91364-6"},{"key":"BF6601038_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S0093-7754(01)90122-8","volume":"28","author":"A Buzdar","year":"2001","unstructured":"Buzdar A (2001) Endocrine therapy in the treatment of metastatic breast cancer. Semin Oncol 28: 291\u2013304","journal-title":"Semin Oncol"},{"key":"BF6601038_CR3","volume-title":"San Antonio Breast Meeting","author":"LA Carey","year":"2001","unstructured":"Carey LA, Ewend MG, Sawyer L, Dees EC, Sartor CI, Graham M (2001) Disproportionate CNS relapse after aggressive neo-adjuvant chemotherapy. Abstract. San Antonio Breast Meeting. San Antonio"},{"key":"BF6601038_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1053\/ctrv.1999.0151","volume":"26","author":"KL Cheung","year":"2000","unstructured":"Cheung KL, Graves CRL, Robertson JFR (2000) Tumour marker measurements in the diagnosis and monitoring of breast cancer. Cancer Treat Rev 26: 91\u2013102","journal-title":"Cancer Treat Rev"},{"key":"BF6601038_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1212\/WNL.39.6.789","volume":"39","author":"LM DeAngelis","year":"1989","unstructured":"DeAngelis LM, Delattre J-Y, Posner JB (1989) Radiation-induced dementia in patients cured of brain metastases. Neurology 39: 789\u2013796","journal-title":"Neurology"},{"key":"BF6601038_CR6","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","volume":"19","author":"CW Elston","year":"1991","unstructured":"Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403\u2013410","journal-title":"Histopathology"},{"key":"BF6601038_CR7","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1200\/JCO.1998.16.10.3439","volume":"16","author":"R Fossati","year":"1998","unstructured":"Fossati R, Confalonieri C, Torri V, Ghislandi E, Penna A, Pistotti V, Tinazzi A, Liberati A (1998) Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomised trials involving 31,510 women. J Clin Oncol 16: 3439\u20133460","journal-title":"J Clin Oncol"},{"key":"BF6601038_CR8","first-page":"38","volume":"27","author":"M Fournier","year":"2000","unstructured":"Fournier M, Esteva FJ, Seidman AD (2000) Trastuzumab in combination with chemotherapy for the treatment of metastatic breast cancer. Semin Oncol 27: 38\u201345","journal-title":"Semin Oncol"},{"key":"BF6601038_CR9","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1200\/JCO.1984.2.12.1404","volume":"2","author":"RS Gelman","year":"1984","unstructured":"Gelman RS, Taylor SG (1984) Cyclophosphamide, methotrexate and 5-fluorouracil chemotherapy in women more than 65 years old with advanced breast cancer: the elimination of age trends in toxicity by using doses based on creatinine clearence. J Clin Oncol 2: 1404\u20131413","journal-title":"J Clin Oncol"},{"key":"BF6601038_CR10","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/bjc.1982.62","volume":"45","author":"JL Haybittle","year":"1982","unstructured":"Haybittle JL, Blamey RW, Elston CW, Johnson J, Doyle PJ, Campbell FC, Nicholson RI, Griffiths K (1982) A prognostic index in primary breast cancer. Br J Cancer 45: 361\u2013366","journal-title":"Br J Cancer"},{"key":"BF6601038_CR11","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/1097-0142(197703)39:3<1289::AID-CNCR2820390340>3.0.CO;2-F","volume":"39","author":"JL Hayward","year":"1977","unstructured":"Hayward JL, Carbone PP, Heusen JC, Kumaoka S, Segaloff A, Rubens RD (1977) Assessment of response to therapy in advanced breast cancer. Cancer 39: 1289\u20131293","journal-title":"Cancer"},{"key":"BF6601038_CR12","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1177\/014107689108401207","volume":"84","author":"AL Hoe","year":"1991","unstructured":"Hoe AL, Royle GT, Taylor I (1991) Breast liver metastases\u2013Incidence, diagnosis and outcome. J R Soc Med 84: 714\u2013716","journal-title":"J R Soc Med"},{"key":"BF6601038_CR13","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1002\/1097-0142(20000615)88:12+<3073::AID-CNCR26>3.0.CO;2-R","volume":"88","author":"GN Hortobagyi","year":"2000","unstructured":"Hortobagyi GN (2000) Developments in Chemotherapy of breast cancer. Cancer 88: 3073\u20133079","journal-title":"Cancer"},{"key":"BF6601038_CR14","first-page":"1","volume":"127","author":"BM Jaffe","year":"1968","unstructured":"Jaffe BM, Donegan WL, Watson F, Spratt JS (1968) Factors influencing survival in patients with untreated hepatic metastases. Surg Gynaecol Obstet 127: 1\u201311","journal-title":"Surg Gynaecol Obstet"},{"key":"BF6601038_CR15","first-page":"1382","volume-title":"The Breast. Comprehensive Management of Benign and Malignant Disease","author":"KA Johnson","year":"1998","unstructured":"Johnson KA, Kramer BS, Crane JM (1998) Management of pleural metastases in breast cancer. In The Breast. Comprehensive Management of Benign and Malignant Disease, Bland KI, Copeland EM (eds) pp 1382\u20131388. Philadelphia: W.B. Saunders Company"},{"key":"BF6601038_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00000658-198302000-00001","volume":"197","author":"KS McCarty","year":"1983","unstructured":"McCarty KS, Silva JS, Cox EB, Leight GS, Wells SA, McCarty Sr KS (1983) Relationship of age and menopausal status to oestrogen receptor content in primary carcinoma of the breast. Ann Surg 197: 123\u2013127","journal-title":"Ann Surg"},{"key":"BF6601038_CR17","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1001\/jama.1983.03330380069030","volume":"249","author":"AW Mughal","year":"1983","unstructured":"Mughal AW, Hortobagyi GN, Fritsche HA, Buzdar AU, Yap HY, Blumenschein GR (1983) Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancer. JAMA 249: 1881\u20131886","journal-title":"JAMA"},{"key":"BF6601038_CR18","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/0277-5379(90)90080-D","volume":"26","author":"SM O'Reilly","year":"1990","unstructured":"O'Reilly SM, Richards MA, Rubens RD (1990) Liver metastases from breast cancer: the relationship between clinical, biochemical and pathological features and survival. Eur J Cancer 26: 574\u2013577","journal-title":"Eur J Cancer"},{"key":"BF6601038_CR19","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1097\/00007611-198809000-00011","volume":"81","author":"V Patanaphan","year":"1988","unstructured":"Patanaphan V, Salazar OM, Risco R (1988) Breast cancer: metastatic patterns and their prognosis. South Med J 81: 1109\u20131112","journal-title":"South Med J"},{"key":"BF6601038_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1053\/ejso.1999.0761","volume":"26","author":"M Pocard","year":"2000","unstructured":"Pocard M, Pouillart P, Asselain B, Salmon RJ (2000) Hepatic resection in metastatic breast cancer: results and prognostic factors. Eur J Surg Oncol 26: 155\u2013159","journal-title":"Eur J Surg Oncol"},{"key":"BF6601038_CR21","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/BF01840835","volume":"22","author":"JFR Robertson","year":"1992","unstructured":"Robertson JFR, Dixon AR, Nicholson RI, Ellis IO, Elston CW, Blamey RW (1992) Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapy. Breast Cancer Res Treat 22(3): 221\u2013227","journal-title":"Breast Cancer Res Treat"},{"key":"BF6601038_CR22","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1067\/msy.2000.103883","volume":"127","author":"M Selzner","year":"2000","unstructured":"Selzner M, Morse MA, Vredenburgh JJ, Meyers WC, Clavien P-A (2000) Liver metastases from breast cancer: long term survival after curative resection. Surgery 127: 383\u2013389","journal-title":"Surgery"},{"key":"BF6601038_CR23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0002-9343(86)90286-X","volume":"81","author":"MM Sherry","year":"1986","unstructured":"Sherry MM, Greco FA, Johnson DH, Hainsworth JD (1986) Metastatic breast cancer confined to the skeletal system. Am J Med 81: 381\u2013386","journal-title":"Am J Med"},{"key":"BF6601038_CR24","first-page":"6","volume":"26","author":"GW Sledge","year":"1999","unstructured":"Sledge GW, Miller KM (1999) Metastatic breast cancer: the role of chemotherapy. Semin Oncol 26: 6\u201310","journal-title":"Semin Oncol"},{"key":"BF6601038_CR25","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/bjc.1997.124","volume":"75","author":"M Tampellini","year":"1997","unstructured":"Tampellini M, Berruti A, Gerbino A, Buniva T, Torta M, Gorzegna G, Faggiuolo R, Cannone R, Farris A, Destefanis M, Moro G, Deltetto F, Dogliotti L (1997) Relationship between CA15-3 serum levels and disease extent in predicting overall survival of breast cancer patients with newly diagnosed metastatic disease. Br J Cancer 75: 698\u2013702","journal-title":"Br J Cancer"},{"key":"BF6601038_CR26","first-page":"66","volume":"16","author":"SJ Walsh","year":"1989","unstructured":"Walsh SJ, Begg CB, Carbone PP (1989) Cancer chemotherapy in the elderly. Semin Oncol 16: 66\u201375","journal-title":"Semin Oncol"},{"key":"BF6601038_CR27","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1002\/1097-0142(19890301)63:5<976::AID-CNCR2820630532>3.0.CO;2-A","volume":"63","author":"R Yancik","year":"1989","unstructured":"Yancik R, Ries LG, Yates JW (1989) Breast cancer in ageing women. Cancer 63: 976\u2013981","journal-title":"Cancer"},{"key":"BF6601038_CR28","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/jama.285.7.885","volume":"285","author":"R Yancik","year":"2001","unstructured":"Yancik R, Wesley MN, Ries LAG, Havlik RJ, Edwards BK, Yates JW (2001) Effect of age and co-morbidity in post menopausal breast cancer patients aged 55 years and older. JAMA 285: 885\u2013892","journal-title":"JAMA"},{"key":"BF6601038_CR29","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1200\/JCO.1987.5.5.773","volume":"5","author":"JW Zinser","year":"1987","unstructured":"Zinser JW, Hortobagyi GN, Buzdar AU, Smith TL, Fraschini G (1987) Clinical course of breast cancer patients with liver metastases. J Clin Oncol 5: 773\u2013782","journal-title":"J Clin Oncol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6601038.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601038","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601038.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T08:50:25Z","timestamp":1684399825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6601038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,7]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,7]]}},"alternative-id":["BF6601038"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6601038","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,7]]}}}